- Home
- RVTY vs PSO Comparison
RVTY vs PSO Comparison
Compare RVTY & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | PSO |
|---|---|---|
| Founded | 1937 | 1844 |
| Country | United States | United Kingdom |
| Employees | N/A | 17062 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Books |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 9.8B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RVTY | PSO |
|---|---|---|
| Price | $113.47 | $16.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 1 |
| Target Price | ★ $109.67 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 780.4K |
| Earning Date | 05-05-2026 | 02-27-2026 |
| Dividend Yield | 0.34% | ★ 2.36% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $3,311,822,000.00 | N/A |
| Revenue This Year | $6.37 | $5.26 |
| Revenue Next Year | $5.10 | $4.54 |
| P/E Ratio | $315.92 | ★ $14.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.22 | $12.02 |
| 52 Week High | $118.30 | $17.75 |
Technical Indicators
Market Signals| Indicator | RVTY | PSO |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 56.40 |
| Support Level | $95.31 | $16.17 |
| Resistance Level | $116.82 | $17.66 |
| Average True Range (ATR) | 3.66 | 0.34 |
| MACD | -0.20 | 0.02 |
| Stochastic Oscillator | 72.61 | 56.98 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About PSO Pearson Plc
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualifications, testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.